[HTML][HTML] Waning COVID-19 vaccine effectiveness for BNT162b2 and CoronaVac in Malaysia: an observational study
…, T Thevananthan, EV Low, MR Appannan… - International Journal of …, 2022 - Elsevier
Objectives We aimed to investigate and compare waning vaccine effectiveness (VE) against
COVID-19 infection, COVID-19 related ICU admission, and COVID-19-related death for …
COVID-19 infection, COVID-19 related ICU admission, and COVID-19-related death for …
[HTML][HTML] PICK-ing Malaysia's epidemic apart: effectiveness of a diverse COVID-19 vaccine portfolio
…, S Sivasampu, T Thevananthan, MR Appannan… - Vaccines, 2021 - mdpi.com
Malaysia rolled out a diverse portfolio of predominantly three COVID-19 vaccines (AZD1222,
BNT162b2, and CoronaVac) beginning 24 February 2021. We evaluated vaccine …
BNT162b2, and CoronaVac) beginning 24 February 2021. We evaluated vaccine …
Assessment of heterologous and homologous boosting with inactivated COVID-19 vaccine at 3 months compared with homologous boosting of BNT162b2 at 6 …
…, BH Tng, T Thevananthan, MR Appannan… - JAMA Network …, 2022 - jamanetwork.com
Importance Evidence for the timing of booster vaccination after completion of BNT162b2 and
CoronaVac primary vaccination is crucial to guide policy recommendations. Objective To …
CoronaVac primary vaccination is crucial to guide policy recommendations. Objective To …
[HTML][HTML] Estimating the infection burden of COVID-19 in Malaysia
…, CW Ng, A Bulgiba, MR Appannan… - PLOS Neglected …, 2022 - journals.plos.org
Malaysia has reported 2.75 million cases and 31,485 deaths as of 30 December 2021.
Underestimation remains an issue due to the underdiagnosis of mild and asymptomatic cases. …
Underestimation remains an issue due to the underdiagnosis of mild and asymptomatic cases. …
[HTML][HTML] Spatial dynamics and multiscale regression modelling of population level indicators for COVID-19 spread in Malaysia
K Ganasegeran, MFA Jamil, MR Appannan… - International journal of …, 2022 - mdpi.com
As COVID-19 dispersion occurs at different levels of gradients across geographies, the
application of spatiotemporal science via computational methods can provide valuable insights to …
application of spatiotemporal science via computational methods can provide valuable insights to …
[HTML][HTML] Post COVID-19 condition among adults in Malaysia following the Omicron wave: A prospective cohort study
…, MA Syahmi, MD Pathmanathan, MR Appannan… - Plos one, 2024 - journals.plos.org
Post COVID-19 condition is an important public health problem as we emerge from the
COVID-19 pandemic. In this prospective cohort study, we aimed to determine the prevalence of …
COVID-19 pandemic. In this prospective cohort study, we aimed to determine the prevalence of …
[HTML][HTML] Real-world nirmatrelvir-ritonavir outpatient treatment in reducing hospitalization for high-risk patients with COVID-19 during Omicron BA. 4, BA. 5 and XBB …
…, WR Kim, WJ Lee, ZW Teh, MR Appannan… - International Journal of …, 2023 - Elsevier
Objective To determine if nirmatrelvir-ritonavir 300mg/100mg treatment for 5 days in high-risk
outpatients with mild to moderate COVID-19 symptoms was associated with a reduction in …
outpatients with mild to moderate COVID-19 symptoms was associated with a reduction in …
Real-world effectiveness of homologous and heterologous BNT162b2, CoronaVac, and AZD1222 booster vaccination against Delta and Omicron SARS-CoV-2 …
Given emerging evidence of immune escape in the SARS-CoV-2 Omicron viral variant, and
its dominance, effectiveness of heterologous and homologous boosting schedules …
its dominance, effectiveness of heterologous and homologous boosting schedules …
[HTML][HTML] Real-world effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection among adolescents (12 to 17-year-olds) in Malaysia
Objectives In this study, we aimed to investigate vaccine effectiveness (VE) against SARS-CoV-2
infections among adolescents aged 12 to 17 years in Malaysia and examine potential …
infections among adolescents aged 12 to 17 years in Malaysia and examine potential …
[PDF][PDF] Public Health Innovations for COVID-19: Finding, Trusting and Scaling Innovation
M Merten, S Roth, FS Allaudin - 2020 - scholar.archive.org
… ; Maheshwara Rao Appanan of the Disease Control Division, MOH, Malaysia; Louise
Agersnap, head of innovation, World Health Organization (WHO); Ken Carswell, technical officer, …
Agersnap, head of innovation, World Health Organization (WHO); Ken Carswell, technical officer, …